Filing Flows › Biofrontera (BFRI) › Recalls, complaints & regulation
Biofrontera (BFRI): clinical trials
Biofrontera (BFRI) beyond its filings: 1 active clinical trial.
Biofrontera's latest quarter
Biofrontera, Q2 2026: revenue $12.0M (+33% year over year), operating margin -4.4%, net loss $604K, operating cash flow −$1.7M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Biofrontera have?
1 active study on ClinicalTrials.gov, 1 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.